l-carnitine--metabolic functions and meaning in human' The carnitine system cancer metabolic plasticity Intestinal microbiota metabolism of l-carnitine,
Description
To achieve personalized drug therapy and optimize treatment efficacy, the expression status of the molecular markers ER and PR can be assessed to guide drug selection
Common covered indications include recurrent pregnancy loss, unexplained blood clots (thrombosis), family history of MTHFR-related cardiovascular disease, or elevated homocysteine confirmed on a blood panel
2019;29: 29482953.e3
The starting dose of 2.5 mg is intentionally low
Constituents Flavolignans (1.53%) : Silymarin (consisting of silybin A and silybin B), silychristin, silydianin, diastereoisomers isosilybin A and isosilybin B
